Effects of inhaled corticosteroids and inhaled cromolyn sodium on urinary growth hormone excretion in asthmatic children.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a clinical trial.

The aim of this open label, nonrandomized, cross-sectional, one-time study was to determine the influence of these drugs on urinary growth hormone (U-GH) levels in prepubertal asthmatic children.

Why It Was Studied

The current therapeutic strategies for treating asthma focus on suppressing the inflammatory process by using cromones or inhaled corticosteroids (ICS).

There were also nine healthy children who served as a control.

Who Took Part

The abstract describes 47 children taking part.

PubMed indexes the participants as young children, children and teenagers, both men and women.

How the Study Was Run

The design is described as open-label.

Everyone knew when Exogenous HGH, sermorelin & older GHRPs (why they're passed over) was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

What Was Measured

The subject headings attached to it are Administration, Inhalation, Adrenal Cortex Hormones, Analysis of Variance, Anti-Asthmatic Agents, Asthma, Chi-Square Distribution and Cromolyn Sodium.

What This Means in Plain Language

The paper is an open-label study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 47 children.

The publication is from 1998 (Pediatric pulmonology), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.